Hugel Backs Physician-Led Research to Raise K-Aesthetics Profile
Hugel is funding physician-led research to build the clinical evidence base behind Korean aesthetic medicine as it competes globally, Korea Biomedical Review reports.
Topic
Topic
Hugel is funding physician-led research to build the clinical evidence base behind Korean aesthetic medicine as it competes globally, Korea Biomedical Review reports.
Hugel targets 1 trillion won in sales within three years, staking its growth plan on the Korean aesthetics maker's injectable por…
Hugel is targeting Taiwan as a priority growth market for its botulinum toxin Letybo and its wider aesthetic portfolio, aiming to…